Nice approves rimegepant for preventing migraines in cases where at least three previous treatments have failed
Thousands of people in England who get migraines could benefit from a drug that has been approved on the NHS.
The National Institute for Health and Care Excellence (Nice), the drugs regulator, said it was recommending rimegepant for preventing migraines in the approximately 145,000 adults where at least three previous preventive treatments had failed.
More Stories
Rebecca Hendin on life outside our solar system – cartoon
Revealed: Chinese researchers can access half a million UK GP records
Google illegally monopolized online advertising markets, US judge rules